Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$18.1 million.

  • Maravai Lifesciences Holdings' Free Cash Flow fell 497.71% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.3 million, marking a year-over-year decrease of 519.01%. This contributed to the annual value of -$22.2 million for FY2024, which is 136.58% down from last year.
  • Maravai Lifesciences Holdings' Free Cash Flow amounted to -$18.1 million in Q3 2025, which was down 37.58% from -$13.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Free Cash Flow ranged from a high of $162.6 million in Q2 2022 and a low of -$20.5 million during Q4 2024.
  • Moreover, its 3-year median value for Free Cash Flow was -$9.0 million (2023), whereas its average is -$669,273.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Free Cash Flow skyrocketed by 1,786.47% in 2021 and then plummeted by 497.71% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Free Cash Flow (Quarterly) stood at $53.1 million in 2021, then spiked by 75.41% to $93.1 million in 2022, then tumbled by 109.67% to -$9.0 million in 2023, then plummeted by 127.41% to -$20.5 million in 2024, then slumped by 497.71% to -$18.1 million in 2025.
  • Its last three reported values are -$18.1 million in Q3 2025, -$13.1 million for Q2 2025, and -$14.6 million during Q1 2025.